Dr. Daniel M. Kolansky, MD

Dr. Kolansky practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Kolansky's NPI, 1124054812, was assigned on June 24, 2006. Dr. Kolansky graduated from Perelman School of Med at the University of Pennsylvania in 1984. Dr. Kolansky holds Pennsylvania license MD046647L.

Dr. Kolansky's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Kolansky's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Kolansky is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kolansky to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolansky practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kolansky's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kolansky is licensed in Pennsylvania.

CMS data shows 1,419 Medicare services from Dr. Kolansky across 11 procedure codes in 2024, for 631 Medicare patients. Medicare paid $54,812 for them.

CMS counts 631 Medicare patients who saw Dr. Kolansky in 2024. The largest group is 65 to 74, with 286 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kolansky's median patient age at 70, with 37% women.

In 2024, Dr. Kolansky wrote 515 Medicare Part D claims for 134 patients. 93% of them were for generic drugs. CMS names the drug for 411 of them, across 14 drugs with 11 or more claims each, at $24,904 in total drug cost. In 2023, CMS named 399 claims across 13 drugs.

Dr. Kolansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of coronary angioplasty and stenting by Dr. Kolansky, more than 35% of the clinicians it reports for that procedure.

Dmand AI links 49 papers to Dr. Kolansky, published from 2008 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Percutaneous Coronary Intervention, Cardiac Catheterization and Myocardial Infarction. Dr. Kolansky has published most often in Catheter Cardiovasc Interv. Dr. Kolansky's most frequent co-authors are Ashwin Senthil Nathan, MD, Robert Wayne Yeh, MD and James Blankenship, MD.

Dmand AI links Dr. Kolansky to 2 clinical trials. Conditions studied include Coronary Artery Disease, Diabetic Nephropathies and Coronary Disease. Open Payments lists research payments to Dr. Kolansky that name 1 trial.

CMS Open Payments shows 183 general payments to Dr. Kolansky from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 98% of the total. Boehringer Ingelheim Corporate Center GmbH paid the most, $123,138. It also lists 42 research payments totaling $205,432 from 2016 to 2024, naming 1 clinical trial.

Dr. Kolansky graduated from Perelman School of Med at the University of Pennsylvania in 1984.